Moleculin to Report Second Quarter Financial Results on August 11, 2023 and Host Conference Call and Webcast

/PRNewswire/ -- Moleculin Biotech, Inc., (Nasdaq: MBRX) ("Moleculin" or the "Company"), a clinical stage pharmaceutical company with a broad portfolio of drug...

Related Keywords

Houston ,Texas ,United States ,Jenene Thomas ,Linkedin ,Twitter ,Nasdaq ,Prnewswire Moleculin Biotech Inc ,Facebook ,Moleculin Biotech Inc ,Moleculin Biotech Conference ,Moleculin Biotech ,Transcription Modulator ,Nc ,